Literature DB >> 9682001

Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain.

H Miyauchi1, S Hashimoto, M Nakajima, I Shinoda, Y Fukuwatari, H Hayasawa.   

Abstract

Bovine LF (bLF) at concentrations in the range of 50-250 micrograms/ml enhanced the phagocytic activity of human neutrophils as determined by measuring the incorporation of FITC-labeled latex beads by flow cytometry. The stimulatory effect of bLF was not abrogated by hydrolysis with pepsin. Bovine lactoferricin (bLFcin), which is a bactericidal fragment purified from a pepsin hydrolysate of bLF (bLFH), also enhanced the phagocytic activity, whereas, in contrast, the fraction of bLFH depleted of bLFcin showed no stimulatory effect. The phagocytosis-enhancing activity of bLF still remained after washing the neutrophils, following exposure to bLF. Also, bLF pretreatment of the latex beads stimulated their uptake. These results demonstrate that bLF is effective in promoting the phagocytic activity of human neutrophils. This activity appears to be due to its bLFcin domain and may involve dual mechanisms of direct binding to neutrophils and opsonin-like activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682001     DOI: 10.1006/cimm.1997.1246

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  19 in total

1.  Veterinary nutraceutical medicine.

Authors:  C Taillon; A Andreasen
Journal:  Can Vet J       Date:  2000-03       Impact factor: 1.008

2.  Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea.

Authors:  Chien-Chang Chen; Chee-Jen Chang; Tzou-Yien Lin; Ming-Wei Lai; Hsun-Chin Chao; Man-Shan Kong
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

3.  Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.

Authors:  L A Håversen; I Engberg; L Baltzer; G Dolphin; L A Hanson; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes.

Authors:  Shen-An Hwang; Katarzyna M Wilk; Yogesh A Bangale; Marian L Kruzel; Jeffrey K Actor
Journal:  Med Microbiol Immunol       Date:  2007-03-22       Impact factor: 3.402

5.  Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis.

Authors:  H Locht; T Skogh; A Wiik
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 6.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 7.  Beneficial health effects of milk and fermented dairy products--review.

Authors:  L Ebringer; M Ferencík; J Krajcovic
Journal:  Folia Microbiol (Praha)       Date:  2008-12-16       Impact factor: 2.099

8.  Stimulus-dependent impairment of the neutrophil oxidative burst response in lactoferrin-deficient mice.

Authors:  Pauline P Ward; Marisela Mendoza-Meneses; Pyong W Park; Orla M Conneely
Journal:  Am J Pathol       Date:  2008-03-05       Impact factor: 4.307

9.  Lactoferrin modulation of antigen-presenting-cell response to BCG infection.

Authors:  Katarzyna M Wilk; Shen-An Hwang; Jeffrey K Actor
Journal:  Postepy Hig Med Dosw (Online)       Date:  2007       Impact factor: 0.270

10.  Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11).

Authors:  Walter J F M van der Velden; Thijs M P van Iersel; Nicole M A Blijlevens; J Peter Donnelly
Journal:  BMC Med       Date:  2009-09-08       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.